Arrestee Drug Abuse Monitoring (ADAM II)

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
ADAM II IRB Notice of Approval_01-13-2010.pdf	Supplementary Document	Uploaded 2010-01-13	Available
ADAM II Technical Documentation Report_rev.pdf	Supplementary Document	Uploaded 2010-01-11	Available
ADAM II_facesheet_eng 11 29.pdf	Supplementary Document	Uploaded 2010-01-11	Available
NIH ADAM II Cert of Confid-Exp 2-28-2011.pdf	Supplementary Document	Uploaded 2010-01-11	Available
ADAM II Final Instrument 507.pdf	Supplementary Document	Uploaded 2010-01-11	Available
Part B-ADAM II 2009 Statistical Methods OMB Final.doc	Supporting Statement B	Uploaded 2010-01-11	Available
Part A-ADAM II 2009 Justification OMB Final.doc	Supporting Statement A	Uploaded 2010-01-11	Available

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
191750	Arrestee Drug Abuse Monitoring (ADAM II)	Other-null	New

ICR Details

OMB Control No: 3201-0016	ICR Reference No: 201001-3201-002
Status: Historical Active	Previous ICR Reference No:
Agency/Subagency: ONDCP	Agency Tracking No:
Title: Arrestee Drug Abuse Monitoring (ADAM II)
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 03/15/2010
	Date Received in OIRA: 01/14/2010
Terms of Clearance: #

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	03/31/2013	36 Months From Approved
Responses	5,000	0	0
Time Burden (Hours)	1,853	0	0
Cost Burden (Dollars)	1,653,540	0	0

---

Abstract: A purposive, non-probability sample of sentinel sights (not representative of the US as a whole or individual states or other areas that were not surveyed) that replicates the ADAM methodology in order to obtain data comparable to previously established trends in 10 of the prior ADAM sites. ADAM II implements two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use.

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	74 FR 208	10/29/2009
30-day Notice:	Federal Register Citation:	Citation Date:
	75 FR 1	01/04/2010
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

table that charts list of burden

IC Title	Form No.	Form Name
Arrestee Drug Abuse Monitoring (ADAM II)

---

ICR Summary of Burden

table that charts list of burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	5,000	0	0	5,000	0	0
Annual Time Burden (Hours)	1,853	0	0	1,853	0	0
Annual Cost Burden (Dollars)	1,653,540	0	0	1,653,540	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: The increase in Annual Burden from 1667 to 1853 reflects modification in the skip patterns for arrestees who report no recent (past twelve month) drug use. In the original design of the ADAM instrument, the National Institute of Justice was concerned about administering a lengthy interview to arrestees, and decided to exclude arrestees who report no recent illicit drug use from the longer calendar section. This decision was designed to make the ADAM interview (about 20 minutes) as short as feasible and more similar to the older DUF interview (about 10 minutes). However, this has always introduced two problems: loss of important data on all arrestees (housing stability, arrests, incarcerations, drug and psychiatric treatment over the prior year) and confusion in analysis by local users as to whom they were referring (all arrestees or all arrestees admitting use in the prior 12 months). In addition, the skip often produces errors and hesitations in the interview process as the interviewer pauses to check the validity of the skip. In ADAM II the removal of this skip will improve data processing procedures, increase the utility and usability of the data by analysts of all programming skill levels, and will result in a more streamlined personal interview. We anticipate this change will add approximately 2 minutes per calendar line completed for those arrestees who report no drug use in the past 12 months (40% of the total ADAM II sample). On average, we estimate that arrestees who report no recent drug use will be required to complete 3 additional calendar lines, which will result in an overall burden increase of 2.23 minutes per interviewed arrestee (186 annual hours.)

---

Annual Cost to Federal Government: $1,754,862

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 01/14/2010

---